Table 1.
Patients with GBM (n = 57) | Patients with MNG (n = 23) | |
---|---|---|
Male sex (%) | 41 (62) | 11 (48) |
Median age at study entry, years (IQR) | 61 (48–71) | 66 (54–71) |
Median follow‐up durationa, years (IQR) | 0.9 (0.4–1.5) | 2.5 (1.6–2.8) |
Patients alive at the end of follow‐up (%) | 21 (36) | 23 (100) |
IQR: interquartile range; GBM, glioblastoma; MNG, meningiomas.
Follow‐up duration was calculated from the date of diagnosis to date of death or last follow‐up visit whichever came first.